Viral hepatitis: A brief introduction, review of management, advances and challenges

doi:10.13105/wjma.v9.i2.139

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4474)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-5) series.

Item

Count

PDF

191

WORD

214

HTML

2617

Tables (1-5)

319

Sum=3341

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

467

Download

666

Sum=1133

Apr 28, 2021 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Meta-Analysis

ISSN

2308-3840

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Meta-Anal. Apr 28, 2021; 9(2): 139-152
Published online Apr 28, 2021. doi: 10.13105/wjma.v9.i2.139

Table 5 First-line recommended direct-acting antiviral therapies for hepatitis C patients

Genotype	1	2	3	4	5/6
DAA schedule (non-cirrhotic)	Sofosbuvir/Ledipasvir; Or Glecaprevir/Pibrentasvir	Sofosbuvir/Velpatasvir	Sofosbuvir/Velpatasvir	Sofosbuvir/Ledipasvir	Sofosbuvir/Ledipasvir
Duration	8-12 wk	12 wk	12 wk	12 wk	12 wk
DAA schedule (cirrhotic)	Sofosbuvir/Ledipasvir	Sofosbuvir/Velpatasvir	Glecaprevir/Pibrentasvir	Sofosbuvir/Ledipasvir	Sofosbuvir/Ledipasvir
Duration	12 wk	12 wk	8-16 wk	12 wk	12 wk

DDA: Direct-acting antiviral.

Citation: Fagan O, Armstrong P, Merwe KVD, Crosnoi D, Steele C, Sopena-Falco J, Parihar V. Viral hepatitis: A brief introduction, review of management, advances and challenges. World J Meta-Anal 2021; 9(2): 139-152
URL: https://www.wjgnet.com/2308-3840/full/v9/i2/139.htm
DOI: https://dx.doi.org/10.13105/wjma.v9.i2.139